TopBuild (BLD) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
7 Jan, 2026Executive summary
Achieved record 2024 results with $5.33 billion in sales and adjusted EBITDA of $1.08 billion, marking the ninth consecutive year of growth and profit expansion.
Completed eight acquisitions totaling $153.1 million in annual sales and repurchased $966.4 million in shares (~2.5 million shares) in 2024.
Board authorized a new $1 billion share repurchase program, increasing total authorization to $1.2 billion.
Commercial and industrial segments showed growth and a strong backlog, while residential demand remained soft.
Disciplined capital allocation and technology investments supported operational efficiency and shareholder returns.
Financial highlights
Q4 2024 sales were $1.31 billion, up 2% year-over-year, driven by Specialty Distribution; adjusted EBITDA margin improved to 19.7%.
Full-year net sales reached $5.33 billion, with adjusted EBITDA of $1.08 billion and free cash flow of $707 million.
Adjusted EPS for Q4 was $5.13, up 9.4% year-over-year; full-year net income was $622.6 million ($20.29 per share).
Year-end cash and cash equivalents were $400.3 million; total liquidity was $836.5 million.
Net debt leverage ratio at 0.91x trailing 12-month adjusted EBITDA; working capital at 13% of sales.
Outlook and guidance
2025 sales guidance: $5.05–$5.35 billion; adjusted EBITDA: $925 million–$1.08 billion.
Residential sales expected to decline mid-single digits; commercial/industrial to grow low single digits.
Multifamily sales expected down ~30%, single-family flat, commercial/industrial up low single digits.
EBITDA margin guidance midpoint: 19.2%, down 100 bps year-over-year; capex expected at 1.5–2% of sales.
Guidance excludes impact of future M&A; pipeline remains robust.
Latest events from TopBuild
- Q4 2025 sales up 13.2%, 2026 outlook up to $6.225B with strong M&A and commercial growth focus.BLD
Q4 202526 Feb 2026 - Q2 sales up 3.7% to $1.37B, record EBITDA margin, guidance revised on costs and strong backlogs.BLD
Q2 20242 Feb 2026 - Strong demand, robust M&A, and operational gains position the business for 2025 growth.BLD
Jefferies Global Industrial Conference 202422 Jan 2026 - Record Q3 sales, narrowed 2024 guidance, and robust M&A amid margin pressures.BLD
Q3 202416 Jan 2026 - Targeting $9B–$10B sales and $1.7B–$2B EBITDA by 2030 through M&A and operational excellence.BLD
Investor Day 202513 Dec 2025 - 2025 meeting covers director elections, auditor, executive pay, and incentive plan amid record results.BLD
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and compensation votes set for April 28, 2025.BLD
Proxy Filing1 Dec 2025 - Q1 sales fell 3.6% to $1.23B; margins and guidance held firm amid market headwinds.BLD
Q1 202525 Nov 2025 - Q2 2025 sales fell 5%, but strong margins and acquisitions support a positive 2025 outlook.BLD
Q2 202523 Nov 2025